← Leaderboards
Sandra J Lee
Dana-Farber Cancer Inst
$7,497,514
Attributed
$30,874,614
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,874,614 · 7
By mechanism
U01$27,764,230 · 4
R01$1,861,908 · 1
RC1$834,573 · 1
R21$413,903 · 1
Top collaborators
- Harry De Koning22 shared
- Jeanne Mandelblatt22 shared
- Sylvia Katina Plevritis22 shared
- Amy Trentham-Dietz22 shared
- Donald A Berry13 shared
- Oguzhan Alagoz9 shared
- Xuelin Huang9 shared
- Natasha Kay Stout8 shared
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanResearch PersonnelMalignant Breast NeoplasmBreastMalignant NeoplasmsBaseProgramsDiagnosisRecording Of Previous EventsAreaEarly DiagnosisScreeningCostWorking GroupComparativeFutureRisk FactorsWisconsinAffectCessation Of LifeCancer ControlNatural HistoryPoliciesRecurrence
Grant awards (34)
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement$566,636
U01 · FY2025 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,508,560
U01 · FY2024 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,871
U01 · FY2023 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,664
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - Supplement$34,980
U01 · FY2022 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,967,606
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760
U01 · FY2021 · CA
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,963,075
U01 · FY2020 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,479,651
U01 · FY2019 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,740,652
U01 · FY2018 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$140,400
U01 · FY2018 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,760,379
U01 · FY2017 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$231,108
U01 · FY2017 · CA
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,785,514
U01 · FY2016 · CA
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis$356,756
R01 · FY2016 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice and Policy$1,819,268
U01 · FY2015 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$590,778
U01 · FY2015 · CA
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis$372,283
R01 · FY2015 · CA · contact PI
Comparative Assessment of Screening Strategies for Melanoma$225,765
R21 · FY2015 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,314,797
U01 · FY2014 · CA
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis$376,171
R01 · FY2014 · CA · contact PI
Comparative Assessment of Screening Strategies for Melanoma$188,138
R21 · FY2014 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,725,720
U01 · FY2013 · CA
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis$364,538
R01 · FY2013 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,340,092
U01 · FY2012 · CA
Analytical Investigation of Breast Cancer Progression: DCIS, Overdiagnosis$392,160
R01 · FY2012 · CA · contact PI
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,352,685
U01 · FY2011 · CA
Comparative Modeling: Informing Breast Cancer Control Practice & Policy$1,257,743
U01 · FY2010 · CA
Role of Advanced Screening Technologies in Early Detection of Breast Cancer$402,139
RC1 · FY2010 · CA · contact PI
Role of Advanced Screening Technologies in Early Detection of Breast Cancer$432,434
RC1 · FY2009 · CA · contact PI
Breast Cancer: Role of Early Detection, Treatment and Prevention$99,784
U01 · FY2009 · CA · contact PI
Breast Cancer: Role of Early Detection, Treatment and Prevention$247,555
U01 · FY2008 · CA · contact PI
Breast Cancer: Role of Early Detection, Treatment and Prevention$246,192
U01 · FY2007 · CA · contact PI